Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
PDSB: PDS Biotechnology Corporation Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
PDSB
The Story
PDSB
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-146.6%
Financially safe
Stretched
Debt / equity
4.07×
Interest coverage
-5.3×
Current ratio
2.26×
PDS Biotechnology Corporation
PDSB
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
PDS Biotechnology Corporation
PDSB
NASDAQ
·
USD
·
Closed
$0.69
−1.85%
$0.69
−$0.01 (1.85%)
52W Range
17th
pctl
Volume
0.23×
avg
Mkt Cap
38.37M
USD
P/E
-1.0
TTM
Div Yield
–
ann
52W Range
17th
pctl
Volume
0.23×
avg
Market Cap
38.37M
USD
P/E Ratio
-1.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings